منابع مشابه
p53 continues to surprise
As one of the most intensively studied transcription factors, it is unsurprising that p53 is involved in many biological processes, including cell cycle arrest, DNA repair, senescence and apoptosis.1 its activities are mainly regulated by posttranslational modifications and interactions with other cellular components. Over the past few years, p53 has also been linked to redox homeostasis, the b...
متن کاملSurprise, Surprise from Neoclassical Economics to E-life2
We build and describe an agent-based model: the Surprise Game. The game comprises a “world” of 30 fi rms, each of which has to survive (and, if possible, prosper) in its environment, which is nothing more than the other 29 fi rms. Each fi rm has to latch onto one or other of the four strategies that are predicted by the theory of plural rationality but has to relinquish that strategy and latch ...
متن کاملExplanation to Avert Surprise
Most explanation schemes are reactive and informational: explanations are provided in response to specific user queries and focus on making the system’s reasoning more transparent. In mixed autonomy settings that involve teams of humans and autonomous agents, proactive explanation that anticipates and preempts potential surprises can be particularly valuable. By providing timely, succinct, and ...
متن کاملEvidence Continues to Mount
In recent years, numerous groups of investigators have reported primary aldosteronism (PAL) to be much more common than previously thought.1–4 This has followed recognition of the aldosterone/renin ratio (ARR) as an improved, more sensitive method of screening for PAL and the application of ARR testing to a wider population, to include normokalemic, as well as hypokalemic, hypertensive subjects...
متن کاملBiosimilar Development: the Race to Market Continues..
2012 will certainly be memorable as an Olympic year, but it has also seen a flurry of activity in the race to market biosimilar products. Keen to participate in this event, many countries throughout the world have established legal and regulatory pathways which allow manufacture of “copies” of a patent-expired biotherapeutic product. However, these are not simple generics as in the case of smal...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cell Cycle
سال: 2013
ISSN: 1538-4101,1551-4005
DOI: 10.4161/cc.23420